Hospital
Prime Healthcare Huntington Beach, LLC
Prime Healthcare Huntington Beach, LLC was paid $3.71M by Medicaid between Jan 2018 and Dec 2024, across 139 billing codes. Its largest line is 96374, Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance — 8.1% of everything it billed.
33Billing provider infoPRIME HEALTHCARE HUNTINGTON BEACH, LLC
HUNTINGTON BEACH, CA 92647
HUNTINGTON BEACH, CA 92647
33aNPI1083622120assigned 08/04/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.71M
24GClaims344,164
24DCodes billed139
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#238 of 410
Median peer was paid$6.90M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 60,849 | $445K | |
| 2019 | 62,399 | $668K | |
| 2020 | 44,983 | $493K | |
| 2021 | 46,421 | $450K | |
| 2022 | 53,383 | $583K | |
| 2023 | 48,758 | $666K | |
| 2024incomplete | 27,371 | $403K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 8.1% | 8,553 | 7,034 | $302K |
| 0450 | Emergency room services | 8.1% | 31,863 | 27,158 | $301K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 7.9% | 6,130 | 5,065 | $293K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 6.1% | 5,739 | 4,900 | $226K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 1,306 | 1,102 | $197K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.7% | 3,624 | 3,233 | $174K |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 4.7% | 5,324 | 3,824 | $173K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.3% | 1,728 | 1,499 | $124K |
| 96375 | Therapeutic injection; each additional sequential IV push | 3.3% | 5,541 | 4,438 | $124K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.3% | 9,942 | 8,219 | $123K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.9% | 4,211 | 3,682 | $108K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 6,685 | 4,572 | $107K |
127 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 2.4% | 6,177 | $87K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.3% | 1,960 | $84K |
| J3490 | Unclassified drugs | 2.2% | 18,420 | $82K |
| 80053 | Comprehensive metabolic panel | 2.0% | 13,577 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 18,137 | $75K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.8% | 1,948 | $68K |
| G0411 | Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 1.7% | 22,154 | $61K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1.6% | 9,811 | $58K |
| 72125 | Computed tomography, cervical spine; without contrast material | 1.5% | 672 | $56K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.3% | 2,646 | $48K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 6,328 | $47K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 1.3% | 11,238 | $47K |
| Z7502 | 1.2% | 1,202 | $45K | |
| 99283 | Emergency room visit (moderate) | 1.0% | 1,187 | $38K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,850 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 578 | $35K |
| 99199 | Unlisted special service, procedure or report | <1% | 688 | $35K |
| 0270 | <1% | 24,150 | $29K | |
| 83690 | <1% | 7,361 | $27K | |
| 99285 | Emergency room visit (most serious) | <1% | 939 | $26K |
| 84484 | <1% | 5,006 | $26K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 889 | $25K |
| 99284 | Emergency room visit (serious) | <1% | 958 | $25K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,595 | $22K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,698 | $17K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,766 | $17K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,086 | $16K |
| 90715 | <1% | 709 | $16K | |
| 81025 | <1% | 7,019 | $16K | |
| 81001 | <1% | 11,155 | $16K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,008 | $15K |
| 83880 | <1% | 923 | $15K | |
| S9484 | Crisis intervention mental health services, per hour | <1% | 305 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,420 | $14K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 2,632 | $11K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,040 | $11K |
| 87040 | <1% | 2,328 | $11K | |
| 83605 | <1% | 1,852 | $9K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,877 | $9K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,262 | $6K |
| Z7610 | <1% | 540 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 123 | $5K |
| 85730 | <1% | 1,614 | $5K | |
| 82962 | <1% | 2,877 | $4K | |
| 70486 | <1% | 60 | $4K | |
| 73562 | <1% | 280 | $4K | |
| 87186 | <1% | 973 | $4K | |
| 85610 | <1% | 2,050 | $4K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 823 | $4K |
| G0176 | Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more) | <1% | 6,092 | $4K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 685 | $3K |
| 73610 | <1% | 199 | $3K | |
| 99406 | <1% | 599 | $3K | |
| 73130 | <1% | 183 | $3K | |
| 0250 | <1% | 2,693 | $2K | |
| 85379 | <1% | 335 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 547 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 282 | $2K |
| 73630 | <1% | 139 | $2K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 553 | $2K |
| 87070 | <1% | 960 | $2K | |
| 73030 | <1% | 144 | $2K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 394 | $1K |
| 0272 | <1% | 1,951 | $1K | |
| 72131 | <1% | 15 | $1K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 183 | $780.34 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 181 | $759.76 |
| 87088 | <1% | 177 | $705.27 | |
| 85027 | <1% | 905 | $650.87 | |
| 0012A | <1% | 16 | $640.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 183 | $625.81 |
| 96376 | <1% | 569 | $616.51 | |
| 0001A | <1% | 12 | $480.00 | |
| 73110 | <1% | 27 | $416.86 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 14 | $407.54 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 59 | $394.80 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 132 | $376.04 |
| 94762 | <1% | 95 | $356.48 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,884 | $340.86 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 12 | $331.99 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 82 | $312.30 |
| 87205 | <1% | 217 | $300.16 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 328 | $230.75 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 47 | $223.31 |
| 0301 | <1% | 483 | $191.85 | |
| 82550 | <1% | 45 | $184.60 | |
| 10060 | <1% | 16 | $180.00 | |
| 71010 | <1% | 26 | $178.68 | |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 411 | $173.93 |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 14 | $166.03 |
| 29125 | <1% | 65 | $164.34 | |
| 82947 | <1% | 66 | $132.20 | |
| 87184 | <1% | 27 | $87.00 | |
| 87077 | <1% | 18 | $80.96 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 19 | $78.00 |
| 83735 | <1% | 26 | $77.12 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 34 | $70.00 |
| 99070 | <1% | 18 | $65.24 | |
| 87081 | <1% | 14 | $60.91 | |
| 86901 | <1% | 33 | $53.26 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $52.06 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 13 | $47.79 |
| 86900 | <1% | 33 | $47.70 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 129 | $41.67 |
| A4606 | Oxygen probe for use with oximeter device, replacement | <1% | 17 | $36.75 |
| 86850 | <1% | 12 | $25.02 | |
| 87420 | <1% | 12 | $18.97 | |
| 0271 | <1% | 210 | $16.22 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 28 | $9.05 |
| 0636 | <1% | 435 | $8.32 | |
| 81003 | <1% | 29 | $0.50 | |
| 0320 | 0% | 45 | $0.00 | |
| 99152 | 0% | 23 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 21 | $0.00 |
| A4208 | Syringe with needle, sterile 3 cc, each | 0% | 13 | $0.00 |
| 0351 | 0% | 17 | $0.00 | |
| 90840 | 0% | 70 | $0.00 | |
| 0762 | 0% | 32 | $0.00 | |
| 0305 | 0% | 200 | $0.00 | |
| 0710 | 0% | 373 | $0.00 | |
| 0306 | 0% | 168 | $0.00 | |
| G0410 | Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes | 0% | 1,290 | $0.00 |
| 0307 | 0% | 71 | $0.00 | |
| A4615 | Cannula, nasal | 0% | 28 | $0.00 |
| 0324 | 0% | 57 | $0.00 | |
| 0352 | 0% | 47 | $0.00 | |
| 90839 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAVITALA, RADHA (DEPUTY GENERAL COUNSEL)
| Provider | Location | Paid |
|---|---|---|
| Saint Marys Urgent Care LLC | Reno, NV | $2.30M |
| Sana Healthcare Carrollton | Carrollton, TX | $954K |
| Prime Healthcare Services Reno LLC | Reno, NV | $38.22 |
| Prime Healthcare Services Reno LLC | Reno, NV | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.